Description
Personalized, prescription metabolic therapy—clinician-guided and pharmacy-compounded.
Compounded dual GLP-1/GIP peptide injections contain tirzepatide, the same active ingredient used in FDA-approved GLP-1/GIP medications. Tirzepatide acts on two key hormone pathways involved in appetite regulation, glucose control, and metabolic efficiency—helping reduce hunger, improve insulin sensitivity, and support meaningful weight loss when paired with lifestyle changes.
How It Works with ReMDi
Following a comprehensive medical evaluation and lab review, a licensed provider may prescribe this therapy if clinically appropriate. The medication is compounded by an FDA-registered, state-licensed compounding pharmacy and shipped directly to your home for convenient once-weekly use, with ongoing clinical oversight from the ReMDi Care Team.
Formulations may be customized and may include:
- Dual-acting GLP-1/GIP peptide (tirzepatide)
- Glycine to support lean muscle preservation
- Vitamin B12 to support energy and metabolic function
Treatment Details
- Once-weekly injection
- Personalized dosing based on labs and clinical response
- Ongoing provider review and progress monitoring
- Continuous access to the ReMDi Care Team
- Medication compounded and shipped directly to your door
What’s Included
- Compounded medication vial (shipped cold)
- Syringes and alcohol pads
- Provider review and ongoing clinical support
- Expedited shipping
Important Information
ReMDi Health offers a compounded formulation prepared with semaglutide base, not semaglutide salts. Partner pharmacies rigorously vet ingredients and perform third-party testing to ensure sterility, potency, and quality.
ReMDi Health operates independently and is not affiliated with Novo Nordisk, the manufacturer of Ozempic® and Wegovy®. Ozempic® and Wegovy® are FDA-approved medications; Wegovy® is approved for weight management, while Ozempic® is approved for type 2 diabetes and may be prescribed off-label for weight loss.
*Compounded medications are not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, or manufacturing standards. Compounded products may differ in appearance and packaging from commercially manufactured medications.

Reviews
There are no reviews yet.